Updated meta-analysis assessing the risk of amputation with sodium-glucose co-transporter-2 inhibitors in the hallmark cardiovascular and renal outcome trials.
Dimitrios PatouliasChristodoulos PapadopoulosMichael DoumasPublished in: Diabetes, obesity & metabolism (2020)